Data / Form D filings / Promaxo, Inc.
Promaxo, Inc.: Form D filings
Promaxo, Inc., a biotechnology company in Oakland, CA, filed 5 Form D notices with the SEC between 2017 and 2024. The latest, on July 10, 2024, reports $41.9 million sold of a $57.3 million offering to 163 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 70 WASHINGTON ST, STE 407, Oakland, CA, 94607
- Phone
- (215) 300-0525
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1716053
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 10, 2024 | Amendment | $57,304,100 | $41,939,728 | $15,364,372 | 163 | Mar 25, 2024 | sec.gov |
| Apr 8, 2024 | New notice | $36,838,350 | $31,606,277 | $5,232,073 | 104 | Mar 25, 2024 | sec.gov |
| Jan 7, 2021 | New notice | $4,999,996 | $4,177,009 | $822,987 | 4 | Dec 31, 2020 | sec.gov |
| May 21, 2020 | New notice | $30,604,200 | $10,971,981 | $19,632,219 | 69 | May 15, 2020 | sec.gov |
| Sep 22, 2017 | New notice | $7,560,000 | $3,790,007 | $3,769,993 | 10 | Sep 12, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Amit Vohra | Executive Officer, Director | |
| Michael Bartholomew | Executive Officer, Director | |
| Jonathan Chen | Director | |
| Derek Hennecke | Director | |
| Dushyant Chipalkatty | Director | |
| Dinesh Kumar | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jul 8, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Promaxo, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.